Teams
-
GeneVentiv Therapeutics, Inc.
GeneVentiv's AAV8.FVa gene therapy is the first universal gene therapy for all hemophilias and the first to treat inhibitor patients.
-
Orion Therapeutics
from UT Knoxville.Orion Therapeutics is a delivery platform-enabled RNA therapeutics company. We pair a proprietary lipid nanoparticle GENESYS™ delivery platform that entirely excludes ionizable cationic lipids with a vascular RNA therapy pipeline. Our safe,…
-
Verdant Scientific, Inc.
from Emory University.Verdant Scientific is developing a first-in-class, first-in-approach small molecule for the treatment of atopic dermatitis, more commonly known as eczema, which is poised to completely change the treatment of this chronic, inflammatory skin…
-
VivoSphere LLC
from Auburn University.We create human-mimicking artificial tumors for high-throughput drug screening, enabling more accurate identification of promising drugs during the preclinical stage.
